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The internal ribosome entry site (IRES) element located at the 5´untranslated genomic region of various RNA viruses
mediates cap-independent initiation of translation. Picornavirus IRES activity is highly dependent on both its structural
organization and its interaction with host factors. Small molecules able to interfere with RNA function are valuable
candidates for antiviral agents. Here we show that a small molecule based on benzimidazole (IRAB) inhibited foot-and-
mouth disease virus (FMDV) IRES-dependent protein synthesis in cells transfected with infectious RNA leading to a
decrease of the virus titer, which was higher than that induced by a structurally related benzimidazole derivative.
Interestingly, IRAB preferentially inhibited IRES-dependent translation in cell free systems in a dose-dependent manner.
RNA structural analysis by SHAPE demonstrated an increased local ﬂexibility of the IRES structure upon incubation with
IRAB, which affected 3 stem-loops (SL) of domain 3. Fluorescence binding assays conducted with individual aminopurine-
labeled oligoribonucleotides indicated that the SL3A binds IRAB (EC50 18 mM). Taken together, the results derived from
SHAPE reactivity and ﬂuorescence binding assays suggested that the target site of IRAB within the FMDV IRES might be a
folded RNA structure that involves the entire apical region of domain 3. Our data suggest that the conformational
changes induced by this compound on a speciﬁc region of the IRES structure which is essential for its activity is, at least in
part, responsible for the reduced IRES efﬁciency observed in cell free lysates and, particularly, in RNA-transfected cells.
Introduction
In recent years RNA has received great attention being rec-
ognized a major player in many cellular processes.1 The vast
majority of RNA functions depend on RNA structure,2 which
on the other hand impacts on RNA-protein interactions and
contributes to gene expression control in all living organ-
isms.3 Common to most RNA regulatory elements, RNA
structure dictates the function of internal ribosome entry site
(IRES) elements.4 These elements, which were discovered in
picornavirus genomic RNAs,5,6 are in charge of driving trans-
lation initiation in various RNA viruses and a subset of cellu-
lar mRNAs.7,8 IRES-driven translation initiation represents
an alternative mechanism to start protein synthesis under sit-
uations that compromise cap-dependent translation initia-
tion, typically occurring in infected cells. Under normal
situations, however, most eukaryotic mRNAs initiate transla-
tion by a mechanism that depends on the recognition of the
m7GpppN residue (termed cap) located at the 5’ end of most
mRNAs.9
IRES elements exhibit a wide diversity of nucleotide sequen-
ces, RNA secondary structures and trans-acting factors require-
ments, as illustrated by those present in the genome of
picornaviruses and the hepatitis C virus (HCV).10 Foot-and-
mouth disease virus (FMDV) is a member of the Picornaviridae
family that causes a contagious disease in cattle and cloven-
hoofed ungulates. The viral genome consists of a positive polarity
single-stranded RNA of about 8500 bases, encoding a single
open reading frame flanked by a highly structured untranslated
region (UTR) at the 5´end of about 1200 nucleotides.7 Upon
entry into the cell, the viral genome is immediately translated
into a polyprotein that is processed by virus-encoded proteases.
Translation and replication of the viral genome occurs in the
cytoplasm of infected cells. As in all picornaviruses, the viral
genome does not contain the cap structure (m7GpppN) typically
present in cellular mRNAs at its 5’ end. Instead, picornavirus
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5’UTR are longer and contain the IRES element, a heavily struc-
tured region controlling internal initiation of translation.5-6
Functional and structural analysis have shown that the FMDV
IRES is organized in 5 structural domains of which domain 2
includes a polypyrimidine tract that provides the polypyrimidine
tract-binding protein (PTB) binding site.11 Domain 3 consists of
210 nucleotides, the most apical region of which is arranged as a
cruciform structure12 that harbors conserved motifs. Disruption
of these motifs abrogates IRES activity, in addition to altering
distant RNA-RNA interactions.13 The proximal part of domain
3 consists of a long stem interrupted with bulges that include sev-
eral non-canonical base pairs and a helical structure essential for
IRES activity. Domain 4 is organized into 2 hairpin-loops con-
served between FMDV and encephalomyocarditis virus
(EMCV), providing the binding site for the translation initiation
factor eIF4G.14-16 Finally, domain 5 is composed of a hairpin-
loop and a polypyrimidine-rich tract that provides the binding
site for various RNA-binding proteins.17,18
Selective 2´-Hydroxyl Acylation analyzed by Primer Extension
(SHAPE) data revealed a modular organization of the FMDV
IRES region.19 Furthermore, the RNA organization of this IRES
region is affected by the concentration of divalent ions in the
folding buffer20 with the peculiarity that the apical loop of
domain 3 is more flexible at near physiological concentration of
Mg2C (0.5 mM) than at high concentration (6 mM). Given that
RNA structure plays a critical role in the function of regulatory
elements controlling expression of viral proteins, we took advan-
tage of the knowledge of IRES structural features to design com-
pounds potentially inhibiting protein synthesis.
Treatment of picornavirus infected cells with small molecules
such as Ribavirin (a guanosine analog) or Quinacrine (9-aminoa-
cridine derivative) effectively reduce virus titer.21,22 On the other
hand, the nucleic acid-binding ligand acriflavine inhibits protein
synthesis in cell free lysates with specificity for internal initiation
of translation.23 However, the efficacy of most these molecules in
animal models are not well documented and their mode of action
are still poorly understood.
Small molecules capable of interacting with nucleic acids are
candidates to interfere with gene expression.24,25 The benzimid-
azole scaffold is a privileged pharmacophore of many therapeutic
agents.26 Benzimidazole derivatives have also been shown to elicit
a variety of pharmacological effects by interacting with RNA
structural elements. In a search for mimics of aminoglycoside
antibiotics, an NMR-based screening of a compound library
identified a series of benzimidazole hits that bind the bacterial A-
site 16S rRNA.27 Recently, a 2-aminobenzimidazole library has
been screened for binding to RNA internal loops,28 and a bisben-
zimidazole derivative has been reported to bind the expanded
r(CUG) repeats that cause myotonic dystrophy type 1 (DM1),
and to some extent overcome DM1-associated defects.29
In the IRES context, 2-aminobenzimidazole derivatives have
also been shown to interact with the SLIIa structural element of
the HCV-like IRES,30,31 and to interfere with viral multiplication
at low micromolar concentrations.32,33 However, to the best of
our knowledge, their potential to bind other types of IRES ele-
ments as well as cap-dependent translation has not been examined.
Here we show that a small molecule based on benzimidazole
(IRAB) induced a local modification of FMDV IRES RNA struc-
ture and inhibited IRES-dependent translation in RNA-trans-
fected cells as well as in cell free systems. Our data suggest that
the conformational changes induced by this compound on a
region of the IRES structure which is essential for internal trans-
lation initiation is responsible for the reduced IRES activity
observed in cell free lysates and in living cells.
Results
The 2-aminobenzimidazole derivative IRAB preferentially
inhibits IRES-dependent translation in cell free systems
The IRES elements present in various RNA virus consist of
specialized RNA structural elements that govern cap-independent
initiation of translation.7 Because of their lack of conservation
with cellular mRNAs these structural elements provide an attrac-
tive target for antiviral agents. A main goal of this study was to
develop small molecules able to interfere with picornavirus IRES
activity, with special emphasis on FMDV. However, since IRES
elements differ considerably in primary sequence and RNA struc-
ture organization34 the interaction of a particular type of
RNA ligand(s) with different types of IRES elements needs to be
experimentally tested.
IRAB (IRES Aminobenzimidazole Binder) (Fig. 1A) was
devised to be an achiral analog of the 2-aminobenzimidazole deriv-
atives known as Isis-11 (Fig. 1A), an inhibitor of HCV replication
that hinders HCV IRES-mediated translation.32 We reasoned that
chirality does not appear to be a major determinant to account for
the binding of Isis-11 to HCV IRES, since the racemic mixture
and the single enantiomers do not significantly differ in their affin-
ity for the target site.35 When compared with Isis-11, IRAB fea-
tures an additional unsaturated bond at the oxygen-containing
ring that eliminates the single stereocenter of Isis-11 and renders
an aromatic furan ring. It is worth mentioning that an additional
aim in IRAB design was to develop a shorter and more efficient
synthetic route than that described for Isis-11 (Fig. S1).
To directly assess the effect of IRAB on IRES activity we set up
in vitro translation assays using a bicistronic RNA harboring the
picornavirus FMDV IRES between chloramphenicol acetyl trans-
ferase (CAT) and firefly luciferase (Luc) reporters that monitored
on translation efficiency initiated via 5´-dependent or IRES-depen-
dent, respectively (Fig. 1B). Increasing amounts of IRAB were
added to the reticulocyte lysates (RRL) in the presence of a con-
stant amount of the bicistronic RNA. Incorporation of 35S-methi-
onine in the newly synthesized proteins allowed us to monitor the
efficiency of protein synthesis encoded by the first cistron (CAT)
or the second cistron (luciferase). A preferential decrease of lucifer-
ase protein synthesis was observed in the presence of IRAB, reach-
ing about 50% inhibition at 0.5 mM and near complete
inhibition at 2 mM (Fig. 1C). In contrast, only 20% inhibition of
the first cistron (CAT) was observed at 0.5 mM concentration of
the drug. According to two-tail Student´s t-test, the differences
observed at 0.75, 1 and 2 mM of IRAB were statistically signifi-
cant (P < 0.05). Higher concentration (up to 4 mM) of this
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compound still showed a preferential
decrease of luciferase relative to CAT
synthesis.
Further studies conducted to com-
pare the effect of IRAB with Isis-11 in
vitro indicated a similar inhibitory
capacity of these compounds when
tested in RRL (Fig. 1D). In support of
the specificity of the inhibitory effect
of these small molecules, unrelated
potential RNA ligands, such as pep-
toids or peptide nucleic acids (PNAs),
did not affect translation of any of
these reporter genes in vitro (Fig. S2).
Additional in vitro translation stud-
ies using a bicistronic RNA that carries
the HCV IRES indicated a similar
inhibitory effect (Fig. S3), suggesting
certain similarities between these geneti-
cally distant IRES elements. Further-
more, in both cases (IRAB at 0.5, 1,
2 mM, and Isis-11 at 1, 2 mM) there
was a preferential statistically significant
(P < 0.05) effect over IRES-dependent
translation (monitored by luciferase)
compared to 5´end-dependent
Figure 1. Inhibitory effect of IRAB on
the in vitro translation efﬁciency driven
by the FMDV IRES. (A). Chemical struc-
ture of IRAB and the structurally related
compound Isis-11. ( §) denotes racemic
mixture (B) Schematic diagram of the
bicistronic mRNA used in in vitro transla-
tion assays. Initiation of translation of
luciferase (Luc) is IRES-dependent while
translation of chloramphenicol acetyl
transferase (CAT) is cap-dependent. (C)
Inhibitory effect of IRAB on the in vitro
translation efﬁciency. Autoradiography of
translation products synthesized in reticu-
locyte lysates using the FMDV bicistronic
RNA incubated with the indicated
amounts of IRAB. The intensity of Luc and
CAT polypeptides in each lane were
determined by densitometry and shown
relative to the total intensity of the lane
with DMSO alone, which was set at 100%.
Data corresponds to the mean ( §SD) of 3
independent assays. (D) Inhibitory effect
of Isis-11 on the in vitro translation efﬁ-
ciency. Autoradiography of translation
products obtained from in vitro synthe-
sized FMDV bicistronic RNA reporter in
the presence of the indicated amounts of
Isis-11. The intensity of the lanes were
determined by densitometry and shown
relative to the total intensity of the lane
with DMSO alone, which was set at 100%.
Data corresponds to the mean ( §SD) of 3
independent assays.
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translation (monitored by CAT), in
agreement with the data obtained using
the FMDV IRES (Fig. 1C and D).
Moreover, the effect on IRES activity
was also confirmed using a monocis-
tronic HCV RNA (Fig. S4).
Taken together the results obtained
with the bicistronic RNAs, we conclude
that there is a preferential effect of IRAB on IRES-dependent
translation initiation over cap-dependent translation, irrespectively
of the IRES (FMDV or HCV) present in the RNA analyzed.
IRAB inhibits multiplication of FMDV
Next, in order to assess whether IRAB could effectively inter-
fere with picornavirus IRES-dependent translation in living cells,
and therefore affect virus multiplication, we transfected BHK-21
cells with infectious FMDV RNA synthesized in vitro (Fig. 2A).
Virus yield was determined in the supernatant of transfected
monolayers by plaque assays on fresh susceptible cell monolayers.
In addition, cell lysates were recovered at different times to deter-
mine viral protein synthesis. Incubation of RNA transfected cells
with IRAB induced a dose-dependent reduction of the virus titer
24 h post-transfection (Fig. 2B). Furthermore, the virus titer
decrease induced by IRAB (2 mM) was higher than that observed
in the presence of Isis-11 (P < 0.05). These results were fully
supported by the extent of VP1 protein synthesis determined by
western blot (Fig. 2C). While the cells transfected with FMDV
RNA yielded high amounts of VP1, addition of IRAB (2 mM) to
the transfected cells led to severe VP1 reduction 24 hpt. In con-
trast, transfected cells treated with Isis-11 showed a lower decrease
of VP1 at the same post-transfection time. Equal amount of total
protein loading control was verified using anti-tubulin antibody.
Cells treated with either Isis-11 or IRAB (1 or 2 mM) contin-
ued proliferating during more than 48 hours, although with a
slower doubling time than the untreated cells (Fig. S5A). This
inhibitory effect on cell growth was not accompanied by cell
monolayer detachment at the concentration inducing decrease in
viral protein synthesis and virus yield (Fig. S5B).
These results enable us to conclude that IRAB exerts an inhib-
itory effect on FMDV multiplication, which is consistent with
the capacity of this compound to inhibit IRES-driven protein
synthesis.
Figure 2. (A). Schematic representation
of the FMDV viral genome. A gray line at
the 5´end depicts structural elements,
including the S hairpin, the polyC tract
(Cn), 2–4 pseudoknots (Pk), and the cis rep-
licative element (cre), followed by the IRES
element depicted by a solid black line. A
solid gray rectangle represents the viral
polyprotein with indication of the region
encoding the capsid protein VP1. The 3´
UTR consists of 2 stem-loops followed by a
poly(A) tail (An). (B) Analysis of virus multi-
plication in the presence of IRAB. Viral yield
reduction induced by increasing amounts
of IRAB (black bars) or Isis-11 (striped bars).
In vitro synthesized FMDV RNA (50 pg) was
transfected in IRAB treated BHK-21 cell
monolayers, in duplicate wells. Virus yield
was determined using fresh cells mono-
layers as the number of plaque forming
units (PFU)/ml in the supernatant 24 hpt,
shown relative to the control RNA which
was set at 100%. Values represent the
mean and standard deviation of triplicate
assays. P values were calculated using two-
tail Student´s t-test; differences were con-
sidered signiﬁcant when P< 0.05. (C) Anal-
ysis of the effect of IRAB on viral proteins.
Western blot of viral protein VP1 accumu-
lated in transfected BHK-21 cells 24 hpt
incubated with the indicated concentra-
tion of IRAB and Isis-11; anti-tubulin was
used as loading control.
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IRAB induces a local structural reorganization of the
IRES element
RNA structure plays a key role in IRES-dependent transla-
tion.10 Since incubation of IRAB with RNAs effectively inhibited
internal initiation driven by the FMDV IRES in in vitro transla-
tion assays, we used SHAPE chemistry to analyze whether this
compound had any influence on the conformation of the IRES
structural organization. SHAPE probing is a quantitative method-
ology that reports on RNA flexibility at nucleotide-resolution,
allowing the study of long RNA molecules in solution.36,37 RNA
transcripts synthesized in vitro carrying the IRES element upstream
of the luciferase ORF were incubated with increasing concentra-
tions of IRAB (2, 10 and 20 mM) prior to NMIA treatment,
which selectively reacts with ribose 2’-hydroxyl groups of confor-
mational flexible nucleotides forming adducts.38 Reactive positions
were subsequently detected as RT stops in primer extension reac-
tions conducted with radiolabeled primers. Four primers spaced all
along the IRES sequence generated overlapping readings allowing
the study of the entire region.20 In all cases the background values
observed in the NMIA (-) RNA were subtracted from the NMIA-
treated RNA prior to SHAPE data normalization.39
The mean SHAPE reactivity values obtained for free RNA
and IRAB-treated RNA (20 mM) is shown in Figure 3A.
Nucleotides with normalized reactivity >0.5 (red shaded) are
considered to be highly flexible, likely unpaired. Nucleotides that
showed very low reactivity values (<0.2) are putatively involved
in base pairing or in tertiary interactions. Nucleotides with
SHAPE reactivity between 0.2 and 0.5 (yellow shaded) are con-
sidered to be moderately reactive.
The SHAPE reactivity profile obtained for the free RNA plot-
ted on the secondary RNA structure (Fig. 3B) is in full agreement
with earlier data20 as well as with chemical and enzymatic RNA
probing.40 Predicted base-paired regions showed no or low reac-
tivity while most of the predicted loops and internal bulges
showed moderate to high reactivity. In particular, the apical
region of domain 3 (D3) showed SHAPE reactive nucleotides
within specific motifs located in the loop of SL1, the hexaloop
and the GNRA motif of SL3A, the RAAA motif, the 6 nt-loop
of SL3C and the C-rich bulge (Fig. 3B).
Upon treatment of the IRES with
IRAB, the apical region of domain 3
showed significant reactivity changes
relative to free RNA (Fig. 3C, depicted
by red dashed rectangles, nts marked
Figure 3. Modiﬁcation of SHAPE reactiv-
ity proﬁle upon incubation of the IRES
RNA with IRAB. (A) SHAPE reactivity pro-
ﬁles of the IRES folded at 0.5 mM Mg2C in
the absence (free RNA) or in the presence
of IRAB (20 mM). Values correspond to the
mean SHAPE reactivity ( §SD) of at least 3
independent assays. SHAPE reactivity is
represented in a colored scale in which 0
indicates unreactive nucleotides and the
average intensity at highly reactive nucleo-
tides is set to 1.0. Nucleotide positions are
indicated on the x-axis. Domains 1, 2, 3, 4
and 5 of the IRES are indicated below the
corresponding nt position. A broken rectan-
gle depicts the region harboring main reac-
tivity changes. (B) Secondary structure of
free RNA according to SHAPE reactivity.
Nucleotides are colored according to their
reactivity, a dot is positioned every 10 nt,
numbers are indicated every 50 nt. Stem-
loops (SL1, SL3A and SL3C) and motifs (hex-
aloop, GNRA within SL3A, RAAA, 6 nt-loop
within SL3C, and the C-rich bulge), located
in domain 3 (D3) apical region referred to
in the text are indicated. (C) SHAPE reactiv-
ity for the RNA treated with IRAB (20 mM).
Red rectangles depict location of nts with
statistically signiﬁcant reactivity modiﬁca-
tion relative to free RNA. p values were cal-
culated using the two-tail Student´s t-test;
differences were considered signiﬁcant
when P < 0.05 or P < 0.01, denoted by 2 or
3 asterisks, respectively.
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with 2 or 3 asterisks denoting P values <0.05 or <0.01, respec-
tively). The statistical significance of the reactivity data obtained
in the presence and absence of IRAB was determined by the two-
tail Student´s t-test (Fig. 3B, C). Specifically, significant
increased reactivity (P < 0.05 or <0.01) was observed in posi-
tions U143, C146, U169C170, U179, and A212A214. Statistically sig-
nificant changes were not observed in the remaining IRES
regions. Incubation of the RNA with lower IRAB concentration
IRAB solutions (2 and 10 mM) showed a dose–dependent reac-
tivity in the same IRES region (Fig. S6).
To quantify the effect of IRAB using an unbiased approach for
visualizing the compound-induced modification of the IRES local
flexibility, we obtained the difference profile39,41 by subtracting the
reactivity of the free RNA from that of the IRAB treated RNA
(Fig. 4A). The difference profile showed increased reactivity or
protected residues that were reported as positive and negative val-
ues, respectively. Nucleotides showing absolute difference reactivity
values 0.3 and P values <0.05 were located in SL1, the hexaloop
and the GNRA motif of SL3A, and the 6-nt loop of SL3C
(Fig. 4A). Furthermore, although no statistical significant reactivity
difference was observed in the residues at the junction of the C-
rich bulge, a partial protection relative to free RNA was detected
in U226U228. We hypothesized that binding of IRAB to domain 3
could give rise to a less constrained apical region structure induced
by a disrupted interaction among the motifs mentioned above.
RNA structure models predicted for the free RNA and the
IRAB-treated RNA using RNAstructure software42 incorporating
the SHAPE reactivity indicated local modification of the second-
ary structure of the apical region of domain 3 (Fig. 4B) resulting
in free energy differences (DG -149.3 kcal/mol for the free RNA
versus -154.4 kcal/mol for the IRAB treated RNA). This differ-
ence may arise from the penalty for base pairing of highly reactive
nucleotides imposed by the pseudo-free energy change term inte-
grated in RNAstructure.43
Together, these results enable us to conclude that incubation
of IRAB with RNAs bearing the FMDV IRES induces a confor-
mational change of domain 3, likely responsible for the inhibi-
tory effect on IRES activity.
Hydroxyl radical cleavage reveals a more solvent accessible
domain 3 structure upon IRAB treatment
The changes in the pattern of SHAPE reactivity observed in
RNA treated with IRAB prompted us to determine the solvent
accessibility of the IRES by hydroxyl radical cleavage footprint-
ing, a methodology that reveals nucleotides buried within the
folded RNA structure.44 Solvent accessibility of the IRES was
probed using Fe(II)-EDTA and H2O2 in a solution of RNA
renatured in the presence or absence of IRAB (20 mM) followed
by primer extension analysis with fluorescently labeled primers,
resolved by capillary electrophoresis. The results yielded cleavage
information at single nucleotide resolution, reporting on solvent
exposure of the IRES nucleotides (Fig. 5A). Yellow and not-
shaded residues indicate buried residues due to structural com-
paction, while pale and dark gray indicate solvent accessible
positions.
Upon folding of the RNA in the presence of IRAB, residues
A181CAA184 and G194GG196 within SL3A of domain 3 became
more accessible to solvent (Fig. 5B, dark gray nucleotides) indi-
cating a lower structural compaction. In contrast, residues U230,
G244GC246 at the C-rich junction became less solvent accessible
(Fig. 5B, light gray, yellow or unmarked nts). These results
together with those shown on Figures 3 and 4, suggest that
IRAB treatment of the IRES induces a less compact RNA struc-
ture of domain 3, supporting the hypothesis that this RNA ligand
perturbs the tertiary structure of this region.
Binding of IRAB to the FMDV IRES requires at least
the apical region of domain 3
Although HCV and FMDV IRES elements are genetically
distant, short structural motifs appear to be conserved between
these RNA regulatory elements. For instance, the HCV IIa and
the FMDV SL3A subdomains share partial RNA structure simi-
larity, such as the AACUA pentaloop (A53-A57) and the
AACUCC hexaloop (A166-C171), respectively, within a stable
stem-loop (Fig. 6A). This striking conservation, together with
the results of SHAPE probing, prompted us to determine
whether subdomain SL3A could be the target of IRAB. To this
end, an oligoribonucleotide (SL3A/AP167, Fig. 6A) bearing the
FMDV SL3A sequence and labeled with 2-aminopurine at the
A167 position was used in fluorescence assays (Fig. 6B). When
the FMDV SL3A/AP167 oligoribonucleotide was titrated with
IRAB, a dose-dependent increase in fluorescence was observed,
consistent with a conformational change that displaces and
unstacks the fluorescent base analog from the interior of the
RNA bulge. Positive binding of both IRAB and Isis-11 to
SL3A/AP167 was determined (EC50 of 18.62 and 15.49 mM,
respectively, Fig. 6D). Next, we attempted to determine whether
other structural motifs (Fig. 6A) of the apical region of the
FMDV IRES could behave as the target of these compounds. As
shown in Figure 6D, IRAB did not bind to SL3A/AP180
(labeled in the GNRA motif). Since SL3A/AP167 and SL3A/
AP180 differ exclusively in the AP-labeled position, the lack of
binding to SL3A/AP180 (EC50 >100 ) indicates that IRAB is
not an unselective RNA ligand. Rather, it shows a preferential
binding to the AACUCC hexaloop of the SL3A subdomain over
the GNRA loop.
Additional fluorescence experiments were carried out using the
oligoribonuclotide C-rich/AP239, which contains a large loop rich
in AC sequences. The results indicated that C-rich/AP239 was a
poor ligand of both IRAB (EC50 60.26) and Isis-11 (>100). Fur-
ther studies aimed to determine whether the binding affinities
could be improved in the presence of a different structural motif
as a consequence of a tertiary interaction were done using equimo-
lar mixtures of two FMDV oligoribonucleotides. The results of
these binding assays showed that the unlabeled C-rich oligoribo-
nucleotide (same sequence as C-rich/AP239 but is not labeled)
behaved as a competitor for the IRAB binding to SL3A/AP167,
giving rise to higher EC50 values (29.17, Fig. 6D).
In parallel, an HCV subdomain IIa oligoribonucleotide con-
struct (SLIIa/AP54, Fig. 6A), used earlier for binding assays of
Isis-11,30 was also employed to assess IRAB affinity. Not
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Figure 4. Impact of IRAB on IRES local ﬂexibility. (A) Domain 3 SHAPE difference plot of IRAB treated RNA relative to the untreated RNA. Red bars
depict positions with positive value of SHAPE differences while blue bars depict positions with negative values. (B) RNA structure model predicted by
RNAstructure software imposing the SHAPE reactivity values (nts 133 to 250) for the free RNA (left) and the IRAB-treated RNA (right). The position of
motifs refer to in the text are indicated on the free RNA structure. Red letters depict nts with absolute SHAPE differences higher than 0.3; font size reﬂects
the magnitude of SHAPE difference. Blue letters indicate nts with absolute difference > ¡0.3. Unmarked nts have a probability >99% of adopting the
predicted conformation, yellow circles indicate probabilities >95%, light to dark green circles indicate probabilities >90, >80 or >70% while light to
dark blue circles reﬂect probabilities> 60 or >50%, respectively.
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surprisingly, IRAB was found to bind SLIIa/AP54 with an affin-
ity similar to that of Isis-11, even a bit higher (Fig. 6C and D).
This result suggests that the 2 inhibitor compounds likely induce
similar conformational changes in the HCV IRES subdomain
IIa.30,35
To assess the target selectivity of IRAB and Isis-11 for both
HCV and FMDV IRES subdomains, fluorescence titrations were
also performed in the presence of a 10-fold molar excess of com-
petitor tRNAmix, which corresponds to about 27-fold nucleotide
excess in the case of SL3A/AP167 and 23-fold in the case of
SLIIa/AP54. The EC50 determined for the mixtures of tRNA
and either SL3A/AP167 or SLIIa/AP54 are higher than those
found for the oligonucleotides alone, as often in this kind of
competition experiments.25 From these data, the degree of selec-
tivity of the ligands for their respective targets can be calculated
as the ratio of [EC50 with tRNA] to [EC50 without tRNA]
(Fig. 6D). The selectivities found rule out the possibility of
IRAB and Isis-11 being promiscuous ligands. Interestingly, and
contrary to what could be speculated for the more extended aro-
matic system of IRAB as compared to Isis-11, IRAB shows better
selectivity than Isis-11 on both IRES subdomains. This result
highlights that the so far unexplored extended aromaticity of
IRAB-like compounds should not be a handicap to allow for the
development of more selective IRES ligands.
These results, in conjunction with the SHAPE reactivity data,
suggest that the target site of IRAB within the FMDV IRES
might be a folded RNA structure that involves the entire apical
region of domain 3. It is worth noting that the conformational
changes induced by the IRAB compound on FMDV IRES are
dissimilar to those described for the interaction of HCV IRES
with Isis-11 (and most probably IRAB). Isis-11 showed binding
to a chimeric HCV subdomain IIa bulge, leading to a conforma-
tional change that widens the interhelical angle.30,35,45 It remains
to be established whether there is a different flexibility of the
bulges of HCV IIa and FMDV 3a subdomains that may account
for the observed differences in binding affinities.
Discussion
In this work we have used a molecular design approach aimed
at interfering with internal initiation translation driven by the
FMDV IRES. We have prepared a novel benzimidazole com-
pound (IRAB) and found that i), IRES activity is preferentially
inhibited upon addition of IRAB to cell-free lysates; ii), incuba-
tion of IRAB with BHK-21 cells transfected with in vitro synthe-
sized viral RNA leads to a decline in virus yield and viral protein
synthesis; iii), IRAB induces a local perturbation of the IRES
structure that correlates with the inhibitory effect of this com-
pound; iv), the target site of IRAB on the HCV and the FMDV
IRES differs in sequence composition and RNA structure.
Our strategy for the design of an Isis-11 analog as IRES-
dependent translation inhibitor has proven to be relevant, since
IRAB is much easier to obtain than Isis-11 (and other Isis-related
molecules), and its lack of chirality does not hamper its binding
to RNA secondary structural motifs but rather increases its selec-
tivity for the target sites, at least in the cases here reported.
The observation that IRES activity is inhibited in in vitro
translation assays at lower concentration of IRAB than cap-
dependent translation initiation emphasizes the usefulness of this
RNA ligand to specifically interfere viral RNA multiplication.
Indeed, different synthetic molecules targeting specific RNA
motifs essential for viral RNA multiplication have been exploited
as therapeutic agents.46-51 Furthermore, the IRES-inhibitory
property of IRAB was observed both in in vitro translation assays
using cell free lysates and in cells transfected with infectious RNA
revealing that the primary targeted event is viral RNA translation,
which is IRES-dependent.7 In agreement with this, a specific
decrease of viral protein synthesis occurred in transfected cells
concomitantly to a reduction in virus yield in the presence of
IRAB (2 mM). Noteworthy, cells continued dividing in the pres-
ence of either Isis-11 or IRAB during 72 hours, although with a
slower doubling time than the untreated cells (Fig. S5A). This
inhibitory effect on cell proliferation, however, was not accompa-
nied by cell monolayer detachment at the concentration inducing
decrease in viral protein synthesis and virus yield reduction
(Fig. S5B).
The inhibition of gene expression observed in susceptible cells
transfected with infectious RNA may depend on the interaction
of the IRES with trans-acting factors present in different concen-
trations within the cell cytoplasm, interactions with other cis-act-
ing RNA elements such as the viral 3´UTR,52 and modification
of host factors in infected cells.53-55 Thus, we could not discard
Figure 5. Hydroxyl radical probing of the IRES upon addition of
IRAB. Secondary RNA structure of the apical region of domain 3 in the
absence (A) or the presence (B) of IRAB. Hydroxyl radical cleavage inten-
sities were normalized to a scale from 0 to 1.5, where 1.0 is deﬁned as
the average intensity of highly reactive residues. Nucleotides with reac-
tivity values lower than half the mean reactivity are deﬁned as solvent-
inaccessible. Solvent-inaccessible positions are shown in white (cleavage
intensity < 0.05) or yellow (cleavage intensity < 0.24), while accessible
nucleotides are shown in pale gray (cleavage intensity > 0.24 to 0.5) or
dark gray (cleavage intensity > 0.5). The position of motifs refer to in the
text are indicated on the free RNA structure. Upside or upside-down
arrows on the IRAB-treated RNA depict nucleotides with increased or
decreased solvent accessibility, respectively.
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that this compound could be acting at various levels affecting
proteins needed for IRES-dependent translation initiation. How-
ever, the inhibition observed in transfected cells are unlikely due
to type I interferon (IFN) production since hamster BHK-21
and swine IBRS-2 cell lines have an inactive type I IFN system in
response to FMDV infection.56
Our study provides evidences for changes in local flexibility of
the IRES structure upon incubation of the RNA with IRAB,
leading to a local perturbation of the RNA structure of the apical
region of domain 3. This IRES region,
which plays a critical role in IRES func-
tion, harbors conserved motifs that have
been proposed to be involved in distant
interactions likely generating a compact
RNA structure.13,57,58 Specifically,
SHAPE probing of the IRES upon
incubation with IRAB showed increased
local flexibility involving residues of the
hexaloop and the GNRA motif of
SL3A, in addition to SL3C and SL1,
while U226U228 (located at the junction
of the C-rich loop) were partially protected. Hence, disruption of
distant interactions among the loops mentioned above would be
accompanied by a less accessible C-rich bulge toward NMIA
(internally base-paired, as predicted by RNAstructure software).
The increase in SHAPE reactivity of residues within D3 apical
loops after IRAB-treatment suggests a perturbation of RNA
structure according to RNAstructure software. Differences in
SHAPE reactivity induced by IRAB in SL1 (U143 and C146) and
the junction with the C-rich bulge (U226U228) would result in
Figure 6. Fluorescence binding assays.
(A) 2-Aminopurine labeled oligonucleotides
within the FMDV and HCV IRES used in this
study. A red circle on each oligonucleotide
depicts the labeled residue, and a red rect-
angle depicts the position of each oligonu-
cleotide within the corresponding IRES
element. (B) Fluorescence proﬁle for the
titration of 0.5 mM SL3A/AP167 with IRAB
(from 50 nM to 130 mM). The arrow indi-
cates the changes in SL3A/AP167 ﬂuores-
cence produced by increasing amounts of
IRAB (top panel). Fitting of the correspond-
ing dose-response curve for the calculation
of the EC50 value (bottom panel). (C) Fluo-
rescence proﬁle for the titration of 0.5 mM
SLIIa/AP54 with IRAB (from 20 nM to
13 mM). The arrow indicates the changes in
SL3A/AP167 ﬂuorescence produced by
increasing amounts of IRAB (top panel). Fit-
ting of the corresponding dose-response
curve for the calculation of the EC50 value
(bottom panel). (D) Binding afﬁnities
(EC50 § standard deviation) and selectiv-
ities of IRAB and Isis-11 for the 2-aminopur-
ine labeled oligonucleotides shown in
Figure 6A. The EC50 of SL3A/AP167 C C-
rich was determined using equimolar
amounts of labeled SL3A/AP167 and unla-
beled C-rich oligonucleotide. The EC50 of
SL3A/AP167 C tRNA and SLIIa/AP54 C
tRNA were determined by performing ﬂuo-
rescence titrations in the presence of a 10-
fold molar excess of competitor tRNAmix.
The later data were used to calculate the
selectivities of the ligands for the given oli-
gonucleotide, expressed as the ratio of
[EC50 with tRNA] to [EC50 without tRNA].
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structural rearrangements as a consequence of the penalty
imposed by the RNAstructure software for highly or moderately
reactive nucleotides to form base pairs. In support of this hypoth-
esis, a mutational analysis carried out on SL1 residues showed
that disruption of the stem reduced IRES activity whereas com-
pensatory mutations restoring the secondary structure recovered
translation.59
Although the nucleotides involved in tertiary interactions
remain elusive, our results support the existence of a complex net-
work of long-distant interactions within this IRES region. This
hypothesis is in agreement with earlier proposals in which
nucleotides belonging to the GNRA motif, the RAAA stem-loop
and G240 within the C-rich bulge are linked in the three-dimen-
sional RNA structure.12,57 As demonstrated by mutational and
RNA probing studies, domain 3 plays a fundamental role in dic-
tating the formation of a constrained structure likely providing
the correct orientation to recruit the ribosome subunits to the ini-
tiation site.10 Therefore, the conformational changes induced by
IRAB would result in a misfolded IRES structure leading to
diminished internal translation initiation, as observed in the
translation assays reported here.
Attempts to identify specific target sites of IRAB within the
IRES using short stem-loops showed that the FMDV SL3A alone
is enough to support binding to this compound. However, the
EC50 value (18.62 mM) of the SL3A/AP167-IRAB interaction
measured by fluorescence assays, together with the results of
SHAPE reactivity of the IRAB-treated IRES RNA, strongly sup-
port the hypothesis that the entire apical region of domain 3 may
be important for IRAB binding.
An additional question is whether the affinity measured with a
single stem-loop of the IRES can explain the translation inhibi-
tion activities of this compound. As previously observed with
other RNA ligands, a relative weak EC50 (around 10 mM) does
not imply poor inhibitor activity, as shown for TAR-Arginina-
mide or neomycin-16S rRNA complexes.60,61 Although the inhi-
bition induced by the IRAB benzimidazole compound is
detected at a concentration of 1 to 2 mM in in vitro translation
assays, the conformational changes induced on the RNA struc-
ture of the full-length IRES in the context of a functional mRNA
were detectable at 10-fold higher concentration (20 mM) by
SHAPE methodology. Taken together, these results indicate that
subtle structural changes of the IRES conformation could lead to
drastic effects over its activity. Moreover, it also underscores the
difficulty in correlating biological activities with data obtained
using 2 techniques with different sensitivities, SHAPE probing
and fluorescence assays, that provide information on structural
features of RNAs on distinct context (the entire IRES element or
short oligoribonucleotides).
Taken together, these data suggest that the changes in local
RNA flexibility induced by IRAB on a specific region of the
IRES structure which is essential for its activity is, at least in part,
responsible for the reduced translation efficiency observed in cell
free lysates and, particularly, in viral RNA-transfected cells. Fur-
ther studies will be focused at understanding the mechanistic
insights of this small molecule as IRES inhibitor.
Materials and Methods
IRAB synthesis
IRAB (Fig. 1A) was synthesized in 8 steps from commercially
available 2-chloro-6-fluorobenzaldehyde (Sigma-Aldrich) as out-
lined in Figure S1. Isis-11 was prepared as a mixture of enan-
tiomers according to a previously published procedure with
minor modifications.33 The identity and purity of all the com-
pounds were confirmed by mass spectrometry as well as 1H- and
13C-NMR spectroscopy. Full experimental details can be pro-
vided upon request.
RNA synthesis
The constructs expressing the FMDV and HCV IRES RNAs
were previously described.62 For RNA structural analysis RNA
was synthesized in vitro using SphI linearized plasmid; to prepare
RNA for translation assays, the plasmid was linearized with
Not1. Transcription was performed using T7 RNA polymerase.
The plasmid pMT28, encoding a cDNA copy of FMDV C-S8c1
genome, was described previously.63 Following NdeI lineariza-
tion, RNA was synthesized in vitro using SP6 RNA polymerase.
DNA template was removed by RQ1 DNase treatment, followed
by phenol extraction and ethanol precipitation. Synthesis of full-
length products was verified by gel electrophoresis.
In vitro translation assays
In vitro translation was conducted in a reaction mix contain-
ing 6.5 ml of nuclease-treated rabbit reticulocyte lysates (RRL)
(Promega), 0.5 ml (0.5 mM) amino acid mix less methionine,
0.5 ml (6 mCi) 35S-methionine and RNA (250 ng) in a final vol-
ume of 10 ml, incubated at 30C for 60 min. The inhibitory
capability of IRAB was determined using a concentration range
(0.1 to 20 mM) dissolved in DMSO. The reaction was then
treated with RNase A and fractionated in sodium dodecyl sul-
fate-polyacrylamide (SDS-PAGE) gels. The intensity of polypep-
tides synthesized was quantified by densitometry. Efficiency of
protein synthesis measured in 3 independent assays was shown
relative to the intensity of luciferase (LUC) and chloramphenicol
acetyl transferase (CAT) polypeptides translated in the control
RNA reaction, without IRAB.
RNA transfection
Viral RNA (50 pg) synthesized in vitro was transfected into
BHK-21 cell monolayers (5 £ 105 cells) as described.47 Immedi-
ately prior to transfect cells with RNA, a solution of IRAB in
DMSO [ranging from 0.1 to 4 mM in Dulbecco´s modified
Eagle´s medium (DMEM)] was added to the cell monolayer
medium. A mock-transfected cell monolayer was treated in paral-
lel with the same concentration of the compound. Triplicates of
BHK-21 cells grown in 35 mm well dishes, were transfected with
a mixture of RNA-lipofectine (Invitrogen). Three hours post-
transfection (hpt), cell monolayers were washed with DMEM
3 times prior to addition of fresh DMEM supplemented with
5% fetal calf serum (FCS) and the same concentration of the
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chemical compounds. Twenty-four and 48 hpt, 200 ml of the
cell culture supernatant was collected to determine virus yield.
Transfection experiments were repeated at least 3 times.
Cytoplasmic cell extracts were prepared for the determination
of VP1 viral protein 24 hpt, prior to cell detachment, using lysis
buffer (100 ml of 50 mM Tris-HCl, pH 7.8, 120 mM NaCl,
0.5% NP40). Cell lysates were centrifuged at 14,000 RPM for
5 min to remove cellular debris.
Cell viability was monitored by measuring cell number during
72 hours of treatment with Isis-11 or IRAB relative to untreated
cells. For this, cells were seeded at low density in DMEM supple-
mented with FCS in the absence or presence of IRAB and Isis-11
(1 or 2 mM). At the indicated times, cell monolayers were
washed twice with tripsine, and resuspended in DMEM. The
number of cells/ml was determined using a Neubauer chamber.
Assays were done in triplicate.
PFU inhibition assay
Virus yield from 3 independent RNA infectivity assays were
titrated in fresh susceptible IBRS-2 cell monolayers to determine
the capacity of IRAB to inhibit plaque-forming units (PFU).
Monolayers of IBRS-2 cells were infected with serial dilutions of
the supernatant from transfected BHK-21 cells. One hour after
adsorption, the viral inoculum was removed and the cells were
washed 3 times, overlaid with DMEM medium with 0.5% agar
supplemented with 2% FCS. Virus titer (PFU/ml) was scored
24 h post-infection (hpi) by fixing the cells with 2% formalde-
hyde solution and stained with 0.3% crystal violet in 2% formal-
dehyde solution. The viral titer from the 24 and 48 hpt
supernatant was determined by counting the viral plaques. The
virus yield was calculated as the mean of PFU/ml of 3 indepen-
dent assays of FMDV RNA transfected BHK-21 cells incubated
with increasing amounts of IRAB relative to the PFU/ml of
FMDV RNA transfected with no drug, which was set at 100%.
Cell monolayers were used to determine cytotoxicity of the
chemical compounds by cell staining at the end of the treatment.
Western blot analysis
Equal amounts of total protein prepared from BHK-21 trans-
fected cells were resolved in 10% SDS-PAGE, transferred to a
PVDF membrane (Bio-Rad). VP1 protein was detected using a
mouse monoclonal antibody (1:1000)64 followed by goat-anti-
mouse secondary antibody coupled to horseradish peroxidase
(1:2000) (Thermo Scientific), and enhanced chemiluminescence
(Amersham). After stripping using restore western blot stripping
buffer (Thermo Scientific) the same membrane was used to
detect a-tubulin as a loading control using anti-tubulin antibody
(1:5000) (Sigma).
SHAPE reactions
RNA (2 pmol) was treated with N-methylisatoic anhydride
(NMIA) (Invitrogen) as described.57 Prior to NMIA treatment,
in vitro synthesized RNA was renatured by heating at 95C for
2 min, snap cooling on ice for 2 min, and subsequently incu-
bated in a final volume of 18 ml of folding mix (100 mM
HEPES pH 8.0, 0.5 mM MgCl2, 100 mM NaCl) for 20 min at
37C. Folded RNAs were incubated with 2, 10 or 20 mM of
IRAB dissolved in DMSO for 5 min at room temperature.
Then, RNAs were incubated with DMSO (untreated RNA) or
6.5 mM NMIA for 45 min at 37C, precipitated and finally
resuspended in 50 ml of 0.5X TE.
For primer extension reactions, 10 ml of treated and untreated
RNAs were incubated with the appropriate antisense 5’-32P-
labeled primer (5´CTACGAAGCAACAGTG, 5´CCCGGGT
GTGGGTACC, 5´GGAATGGGATCCTCGAGCTCAGGGTC,
5´GGCCTTTCTTTATGTTTTTGGCG). Primer extension
reactions were conducted in a final volume of 16 ml containing
reverse transcriptase (RT) buffer (50 mM Tris–HCl, pH 8.3,
3 mM MgCl2, 75 mM KCl, 8 mM DTT) and 1 mM each
dNTP. The mix was heated at 52C for 1 min, prior to addi-
tion of 100 U of Superscript III RT (Invitrogen) and incubated
at 52C for 30 min. cDNA products were fractionated in 6%
acrylamide, 7 M urea gels, in parallel to a sequence obtained
with the corresponding primer.
SHAPE analysis
For SHAPE data processing, the intensities of RT-stops were
quantified by densitometry using Quantity One software (Bio-
Rad). The reactivity values observed in the untreated RNA
(NMIA-) were subtracted from all the NMIA-treated samples
(free RNA and IRAB-treated RNAs). Quantitative SHAPE reac-
tivity for individual data sets were normalized to a scale spanning
0 to 1.5, in which 0 indicates an unreactive nucleotide and the
average intensity at highly reactive nucleotides is set to 1.0. The
normalization factor for each dataset was determined by exclud-
ing the most-reactive 2% of peak intensities, followed by calculat-
ing the average for the next 8% of peak intensities. All reactivity
values were normalized to this average value to generate the corre-
sponding SHAPE reactivity profiles.39
Data from 3 independent assays were used to calculate the
mean (§SD) SHAPE reactivity. Differences in SHAPE reactivity
induced by incubation of the IRES with IRAB were analyzed by
unpaired two-tail Student´s t-test; differences were considered
significant when P < 0.05.
Absolute differences in SHAPE reactivity  0.3 arbitrary units
and a P-value < 0.05 were taken to be statistically significant.41
RNA structure modeling
RNA structure models incorporating the SHAPE reactivity
values were predicted using RNAstructure and SHAPEKnots
software.42,65 SHAPE reactivity data was imposed as a pseudo-
free energy change constraint together with nearest neighbor
thermodynamic parameters.
Hydroxyl radical footprinting
RNA (2 pmol) was denatured, chilled on ice and incubated in
folding buffer (40 mM MOPS pH 8.0, 80 mM KOAc, 0.5 mM
MgCl2). Fe(II)–EDTA [7.5 mM Fe(SO4)2(NH4)2¢6H2O and
11.25 mM EDTA, pH 8.0], 0.3% hydrogen peroxide and
150 mM sodium ascorbate solutions were freshly prepared before
each experiment.39 Hydroxyl radical cleavage was initiated by
adding 1 ml of Fe(II)–EDTA complex, 1 ml of sodium ascorbate
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and 1 ml of hydrogen peroxide solution to the reaction. A control
reaction lacking Fe(II)–EDTA was performed in parallel. After
incubation at 37C for 30 sec, reactions were quenched and pre-
cipitated by addition of 75% glycerol (1/3 volume), 1 ml of
20 mg/ml glycogen, 1 ml of 3 M NaCl, 2 ml 0.5 M EDTA and
2.5 volumes ice-cold ethanol. RNAs were re-suspended and
reverse transcribed. Primer extension reactions were conducted
using fluorescent-labeled primer 5’-TAGCCTTATG-
CAGTTGCTCTCC-3’. NED fluorophore (Applied Biosystems)
was used for both treated and untreated samples while VIC fluo-
rophore (Applied Biosystems) was used for the sequencing lad-
der, as described.20 cDNA products were resolved by capillary
electrophoresis. Hydroxyl radical cleavage intensities were nor-
malized to a scale from 0 to 1.5, where 1.0 is defined as the aver-
age intensity of highly reactive residues. Nucleotides with
cleavage intensity values lower than half the mean intensity are
defined as solvent-inaccessible.
Fluorescence binding assays
Unlabeled RNA oligonucleotides were custom synthesized
and HPLC purified. 2-Aminopurine (AP)-labeled and HPLC-
purified RNAs were purchased from Integrated DNA Technolo-
gies (IDT). Stock solutions were prepared by dissolving lyophi-
lized oligonucleotides in 10 mM sodium cacodylate buffer,
150 mM NaCl, pH 7.5. RNAs (SLIIa/AP54, SL3A/AP167,
SL3a/AP180 or C-rich/AP239) were heated at 90C for 5 min
followed by slow cooling to room temperature. Fluorescence
measurements were performed on a thermostatted Quanta-Mas-
ter (PTI) spectrofluorometer at 20C. Titrations were carried out
with 0.5 mM RNA and increasing ligand concentration, from
20 nM to 130 mM depending on the target RNA. All fluores-
cence measurements were dilution corrected. Excitation wave-
lenght was fixed at 327 nm, and emission spectra were recorded
over a range of 340–430 nm with a maximum fluorescence signal
at 368 nm. It is worth mentioning that both IRAB and Isis-11
are fluorescent compounds, especially the latter.35 If the excita-
tion wavelenght were fixed at 310 nm, which is the one com-
monly employed for 2-aminopurine binding assays and used in
previous assays of Isis-11,30,45 the dose-response curves could not
be properly adjusted, and the errors became too high (Fig. S7).
By fixing the excitation wavelenght at 327 nm, the interference
of IRAB and Isis-11 in the binding assays was substantially
reduced, even though the desired complete saturation could not
be fully achieved (Fig. 6). EC50 data, which can be equivalent to
dissociation constants only in 1:1 ligand-target interactions, are
the average of at least 2 titrations.
Titrations were also performed in the presence of a 10-fold
molar excess of tRNAmix (Escherichia coli type XXI, strain W)
(Sigma-Aldrich) in order to determine the selectivity ratios
shown in Figure 6D. Experiments were carried out on mixtures
containing tRNAmix and the corresponding RNA (SLIIa/AP54
or SL3A/AP167) in 10 mM sodium cacodylate buffer, 150 mM
NaCl at pH 7.5. In these conditions, the ratios of tRNAmix base
to RNA base were estimated to be 27 in the case of SL3A/AP167
and 23 with respect to SLIIa/AP54.
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